Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

• Claudia M. Denkinger,

  Affiliations Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America, McGill International TB Centre & Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada

  ⨯
• Madhukar Pai,

  Affiliations McGill International TB Centre & Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada, Respiratory Epidemiology & Clinical Research Unit, Montreal Chest Institute, Montreal, Montreal, Quebec, Canada

  ⨯
• David W. Dowdy

  * E-mail: ddowdy@jhsph.edu

  Affiliations Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Center for Tuberculosis Research, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States of America

  ⨯